Delivery of tacrolimus with cationic lipid-assisted nanoparticles for ulcerative colitis therapy
- 14 May 2018
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 6 (7) , 1916-1922
Abstract
Oral drug delivery with nanoparticles has demonstrated great potential for drugs with poor bioavailability. Efficient delivery is possible by overcoming both the mucus and epithelial barrier of the gastrointestinal tract (GIT). Cationic lipid-assisted nanoparticles (CLANs), which are composed of amphiphilic block copolymers and cationic lipids, have been well studied and have been proved beneficial for drug delivery. In this study, CLANs prepared by poly(ethylene glycol)-block-poly(lactic acid) (PEG-b-PLA) and 1,2-dioleoyl-3-trimethylammonium-propanechloride (DOTAP) or N,N-bis(2-hydroxyethyl)-N-methyl-N-(2-cholesteryloxycarbonyl aminoethyl)ammoniumbromide (BHEM-Chol) were used for oral delivery of tacrolimus (FK506) for ulcerative colitis treatment. The average size of these nanoparticles is around 110 nm and the zeta-potential is 35 mV. These nanoparticles maintained their size in buffer solutions of pH 1.2 and 6.8, and slowly release the encapsulated drug. CLANs can be accumulated in the colon and transported through the epithelium in the colitis model by dextran sulfate sodium salt (DSS), leading to attenuation of DSS-induced colitis.Keywords
Funding Information
- Guangdong Innovative and Entrepreneurial Research Team Program (2017ZT07S054)
- National Natural Science Foundation of China (51633008, 51390482)
- Ministry of Education of the People's Republic of China (B17018)
This publication has 35 references indexed in Scilit:
- Treatment of IBD: Where We Are and Where We Are GoingAmerican Journal of Gastroenterology, 2015
- Drug delivery strategies in the therapy of inflammatory bowel diseaseAdvanced Drug Delivery Reviews, 2014
- Nanoparticle- and biomaterials-mediated oral delivery for drug, gene, and immunotherapyAdvanced Drug Delivery Reviews, 2013
- Optimization of conventional therapy in patients with IBDNature Reviews Gastroenterology & Hepatology, 2011
- Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: A prospective cohort studyInflammatory Bowel Diseases, 2010
- Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestinesNature Materials, 2010
- Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than virusesProceedings of the National Academy of Sciences, 2009
- Altering Mucus Rheology to “Solidify” Human Mucus at the NanoscalePLOS ONE, 2009
- Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus BarrierAngewandte Chemie International Edition, 2008
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007